Related Experiment Videos
Clinical Trials in Older Adults with Cardiovascular Multimorbidity: A Perspective on Pragmatic Trial Design
Clara Bonanad1,2,3, Didier Sánchez-Ospina4, Sergio García-Blas1,2,3
1Cardiology Department, University Clinical Hospital of Valencia, 46010 Valencia, Spain.
Insights
Aging populations face cardiovascular disease challenges. Current trials often exclude frail older adults, necessitating new, geriatric-focused research designs for better real-world applicability.
Area of Science:
- Geriatric Cardiology
- Clinical Trial Methodology
- Cardiovascular Disease Research
Background:
- Population aging increases cardiovascular disease (CVD) burden in older adults with multimorbidity and frailty.
- Existing randomized clinical trials (RCTs) often use homogeneous participants, limiting applicability to complex geriatric populations.
- Geriatric cardiology requires trial designs that better reflect real-world patient complexity.
Purpose of the Study:
- To conduct a comparative methodological analysis of two European cardiovascular RCTs (HI-COR-65 and SENEKA).
- To propose a geriatric-oriented framework for improving future cardiovascular trial design in older adults with multimorbidity.
- To address limitations in current trial designs regarding representativeness, patient complexity, and outcome relevance.
Main Methods:
- Qualitative comparative analysis of two cardiovascular RCTs across five domains: population representativeness, clinical objectives, exclusion criteria, multidisciplinarity, and patient perspective.
- Evaluation of how trials operationalize geriatric complexity, stratification, and patient-centered outcomes.
- Review of intervention models and participation burden.
Main Results:
- Both analyzed trials made progress by including older adults with cardiovascular multimorbidity.
- Recurring limitations include inadequate operationalization of geriatric complexity, potential selection of robust participants, misaligned outcome hierarchies, and predominantly pharmacological, monodisciplinary interventions.
- Current trial designs often fail to fully integrate comprehensive geriatric assessment or patient priorities.
Conclusions:
- Future cardiovascular trials in older adults need pragmatic, complexity-sensitive designs moving beyond chronological inclusion.
- The proposed Comprehensive Geriatric Cardiology (COMGERCARDIO) framework integrates geriatric assessment, adaptive interventions, patient-centered outcomes, and stratified analysis.
- The COMGERCARDIO framework aims to generate scientifically robust, clinically usable, and equitable evidence for aging populations.
Abstract:
Population aging has shifted the burden of cardiovascular disease toward older adults living with multimorbidity, frailty, cognitive vulnerability, functional impairment, and treatment burden. Yet much of the contemporary cardiovascular evidence still derives from randomized clinical trials (RCTs) designed around biologically homogeneous participants, limiting applicability to real-world geriatric cardiology. Our objective was to perform a comparative methodological analysis of two contemporary European cardiovascular RCTs, HI-COR-65 and SENEKA, as illustrative cases and to propose a geriatric-oriented framework for improving trial design in older adults with cardiovascular multimorbidity. We qualitatively compared both trials across five domains: population representativeness, clinical objectives and outcome hierarchy, exclusion criteria, multidisciplinarity, and patient perspective, including participation burden and patient-reported outcomes. Both trials represent important progress by explicitly enrolling older adults with clinically relevant cardiovascular multimorbidity. However, the analysis identified recurring limitations: geriatric complexity is acknowledged but not operationalized through comprehensive geriatric assessment or vulnerability-based stratification; safety and participation requirements may preferentially select robust older adults; outcome hierarchies remain variably aligned with patient priorities; and intervention models are predominantly pharmacological and monodisciplinary. Future cardiovascular trials in older adults should move from chronological inclusion toward pragmatic, complexity-sensitive design. We propose the Comprehensive Geriatric Cardiology (COMGERCARDIO) framework, which integrates baseline geriatric assessment, vulnerability-adaptive interventions, hierarchical patient-centered outcomes, stratified analysis, and implementation evaluation to generate evidence that is scientifically robust, clinically usable, and equitable for aging populations.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Clinical Trials: Overview
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion